This summer, thousands of people descended on a small orchard in California's Central Valley to receive free nectarines. The crowds became so large that the California Highway Patroltemporarily shut the event down because of traffic and safety concerns.
At first glance, it looked like a feel-good story: a farmer sharing his harvest with the community. But that wasn't the whole story.
Third-generation farmer Cesar Mora says he gave away more than 100,000 pounds of nectarines because he couldn't sell them. Some reports estimate that the total giveaway has reached 182,000 pounds.
The giveaway stemmed from a legal dispute over who controls the right to market and sell a specific variety of nectarine. It's a story that raises much larger questions about intellectual property, exclusive supply agreements, and market access.
One of those growers is Cesar Mora, a third-generation farmer in Reedley, California. Mora leases approximately 70 acres, including a 50-acre ranch and another 20 acres used to grow peaches. Only 7.5 acres are planted with the Monalise white nectarine variety at the center of this dispute. Mora says those nectarines represent roughly one quarter of his annual income.
Many commercial fruits are the result of years (or decades) of breeding programs designed to improve sweetness, shelf life, appearance, disease resistance, and shipping performance. Those improvements have value, and so they are increasingly protected through intellectual property and licensing agreements.
According to Bradley Rickard, professor of food and agricultural economics at Cornell University: "A patent allows a breeder to collect a royalty from the fruit trees it sells and/or the fruit that the trees produce."
Another article summarizes the business case this way: "These specialized patents are explicitly designed to protect the massive financial investments required to breed new, highly desirable fruit varieties."
Intellectual property isn't unique to pharmaceuticals or technology. It increasingly shapes agricultural supply chains as well.
Suit and Countersuit
According to court filings, Mora entered into a sublicensing agreement with Giumarra Bros. Fruit Company in 2017.
To quote the Associated Press: "Court filings show Mora signed a sublicensing agreement with Giumarra in 2017 allowing him to grow and sell the Monalise. He entered a marketing agreement in 2019 requiring the fruit to be packed and sold through Giumarra. He said Giumarra recruited him to grow it."
Under that arrangement, Mora agreed to pay: $2.50 per tree in royalties, a 4% production royalty based on gross fruit sales, and sales commissions. Another summary of the agreement provided by The Cooldown explains, "The contract stipulated that Mora would only supply to chosen packagers, & exclusively sold by Guimarra."
Exclusive commercialization agreements exist in many industries. The breeder gains control over quality, branding, and distribution. The grower gains access to a premium product that may command higher prices, but the arrangement will only work if both parties continue to believe the relationship creates value.
Mora has alleged that as much as half of the fruit he delivered to Giumarra in 2020 was rejected, and that this had the net effect of reducing his profits. Giumarra disputes that allegation. The judge overseeing the case ruled that those particular claims could not proceed because the statute of limitations had expired.
According to People magazine's reporting, Mora argues that Giumarra has blocked his market access and rejected his fruit after he delivered it to them.
Mora also claims that in 2022 Giumarra sold his nectarines to Taiwan, a violation of the contract. According to his understanding of the agreement, Giumarra is only supposed to market and sell the nectarines in the U.S. and Canada, but Giumarra disputes that claim.
People magazine adds another element to Mora's allegations: On the reported journey to Taiwan, the temperature was not controlled properly, causing the fruit to spoil."
What followed transformed a commercial disagreement into a story that attracted national attention.
Market Access as Corporate Value
One of the reasons this story resonates with me is that the underlying commercial questions appear across many supply chains.
When one company develops a valuable product (or controls access to it), they may rely on exclusive agreements to protect their investment. Those agreements can create meaningful value by encouraging innovation, helping recover research and development costs, establishing consistent quality standards, and creating recognizable brands.
At the same time, they also introduce dependencies.
If a supplier has only one route to market, if one distributor controls commercialization, if switching supply partners becomes prohibitively expensive… Then a disagreement over quality standards, pricing, territory, or performance can quickly become existential.
.png)
